Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SOPHiA GENETICS (SOPH) Gains from Investment Securities (2023 - 2025)

Historic Gains from Investment Securities for SOPHiA GENETICS (SOPH) over the last 3 years, with Q3 2025 value amounting to -$59000.0.

  • SOPHiA GENETICS's Gains from Investment Securities rose 8342.7% to -$59000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$367000.0, marking a year-over-year increase of 1177.88%. This contributed to the annual value of -$536000.0 for FY2024, which is 3308.36% up from last year.
  • According to the latest figures from Q3 2025, SOPHiA GENETICS's Gains from Investment Securities is -$59000.0, which was up 8342.7% from -$101000.0 recorded in Q2 2025.
  • Over the past 5 years, SOPHiA GENETICS's Gains from Investment Securities peaked at -$1000.0 during Q1 2024, and registered a low of -$555000.0 during Q2 2023.
  • For the 3-year period, SOPHiA GENETICS's Gains from Investment Securities averaged around -$140181.8, with its median value being -$83000.0 (2023).
  • As far as peak fluctuations go, SOPHiA GENETICS's Gains from Investment Securities skyrocketed by 9917.36% in 2024, and later plummeted by 440000.0% in 2025.
  • Over the past 3 years, SOPHiA GENETICS's Gains from Investment Securities (Quarter) stood at -$42000.0 in 2023, then crashed by 285.71% to -$162000.0 in 2024, then skyrocketed by 63.58% to -$59000.0 in 2025.
  • Its Gains from Investment Securities was -$59000.0 in Q3 2025, compared to -$101000.0 in Q2 2025 and -$45000.0 in Q1 2025.